Carvedilol Tablets 6.25 mg Recalled for N-Nitroso Impurity
Glenmark Pharmaceuticals Inc., USA is recalling Carvedilol Tablets USP 6.25 mg due to the presence of N-Nitroso Carvedilol I impurity above the recommended acceptable intake limit. The recall affects 100-count and 500-count bottles distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II drug recall with identified manufacturing deviations (CGMP) and presence of a nitrosamine impurity (N-Nitroso Carvedilol I) above acceptable intake limits, meeting the criterion for Severe classification.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is recalling Carvedilol Tablets USP 6.25 mg in 100-count bottles (NDC 68462-163-01) and 500-count bottles (NDC 68462-163-05). The recall was initiated due to current Good Manufacturing Practice (CGMP) deviations and the presence of N-Nitroso Carvedilol I impurity above the recommended acceptable intake limit.
Affected lot numbers and expiration dates for 100-count bottles include: Lot 19231618 (Mar-25), 19232064 (Apr-25), 19232324 (May-25), 19233369 (Jul-25), 19234162 (Sep-25), and 19240543 (Jan-26). Affected lot numbers for 500-count bottles include: Lots 19231174, 19231199, 19231164 (Feb-25); 19231517, 19231527, 19231566, 19231568, 19231595, 19231618, 19231634, 19231638, 19231448 (Mar-25); 19232043, 19232051, 19232064 (Apr-25); 19232322, 19232324, 19232365, 19232380, 19232389 (May-25); 19232736, 19232743, 19232746, 19232756, 19232757 (Jun-25); 19233369, 19233371, 19233405, 19233416 (Jul-25); 19234162, 19234183, 19234192, 19234204, 19234223, 19234243, 19234263, 19234165, 19234242 (Sep-25); 19234743, 19234774, 19234993 (Nov-25); 19240223, 19240203, 19240211, 19240214, 19240247, 19240249, 19240272, 19240319 (Dec-25); and 19240543 (Jan-26). The affected product has been distributed U.S. nationwide.
Patients taking the affected medication should consult their healthcare provider before stopping the medication or for guidance on obtaining a replacement. Healthcare providers and pharmacists should stop dispensing affected lots immediately.
The recalled product
- Product
- CARVEDILOL (CARVEDILOL)
- Brand
- CARVEDILOL
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Hazard
- nitrosamine-impurity
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- [100-Count Bottles] Lot 19231618
- exp Mar-25
- 19232064
- exp Apr-25
- 19232324
- May-25
- 19233369
- Exp Jul-25
- Lot 19234162
- Exp Sep-25
- Lot 19240543
- Exp Jan-26 [500-Count Bottles] Lots 19231174
- 19231199
- 19231164
- Exp Feb-25
- 19231517
- 19231527
- 19231566
- 19231568
- 19231595
UPCs (4)
- 0368462162019
- 0368462163016
- 0368462164013
- 0368462165010
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CARVEDILOL
- SevereCarvedilol Tablets 12.5 mg Recalled for Impurity Above Limit
FDA (Drugs) · 2025-06-04
- SevereCarvedilol Tablets Recalled Due to N-Nitroso Impurity
FDA (Drugs) · 2025-06-04
- SevereCarvedilol Tablets 25 mg Recalled Due to Impurity Above Acceptable Limit
FDA (Drugs) · 2025-06-04
- ModerateCarvedilol Tablets Recalled Due to CGMP Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- HighCarvedilol Tablets Recalled for Carcinogenic N-Nitroso Impurity Manufacturing Defect
FDA (Drugs) · 2025-02-12
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22